Inactive Instrument

Other languages RedHill Biopharma Ltd. OTC Markets

Equities

REDIF

IL0011223810

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Redhill Biopharma Ltd. Terminates License Agreement for Aemcolo	09/07
RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board	06/06
Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib	06/05
RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035	06/05
RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	24/04
RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	08/04
Redhill Biopharma Says Talicia Gets New US Patent to Treat Helicobacter Pylori Infection	11/03
U.S. government Selects RedHill Biopharma Ltd.'s Opaganib for Evaluation by BARDA and NIH Countermeasures Programs	05/03
Redhill Biopharma Ltd. Announces New Publication of Data from Multiple Experiments in the International Journal of Molecular Sciences	20/02
Redhill Biopharma Closes $8 Million Registered Direct Offering of American Depositary Shares	26/01
RedHill Biopharma to Seek Acquisitions	26/01
Top Midday Decliners	26/01
Redhill Biopharma Launches $8 Million Offering of American Depositary Shares; Stock Falls	25/01
Sector Update: Health Care Stocks Retreat Late Afternoon	21/12
Sector Update: Health Care Stocks Mixed in Wednesday Afternoon Trading	21/12
Redhill Says Opaganib, RHB-107 Combinations With Remdesivir Show 'Robust Synergistic Effect' Against Ebola; Shares Rise	20/12
RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola	20/12
U.S.-LISTED SHARES OF REDHILL BIOPHARMA RISE 2.4% ON ADDITIONAL…	04/12
Redhill Biopharma Says it Received $4.8 Million in Additional Funds for Study of Early COVID-19 Treatment	04/12
Top Premarket Decliners	30/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages RedHill Biopharma Ltd. OTC Markets

Equities

REDIF

IL0011223810

Other languages

Filters